GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Medexus Pharmaceuticals Inc (OTCPK:MEDXF) » Definitions » Book Value per Share

MEDXF (Medexus Pharmaceuticals) Book Value per Share : $1.33 (As of Sep. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Medexus Pharmaceuticals Book Value per Share?

Medexus Pharmaceuticals's book value per share for the quarter that ended in Sep. 2024 was $1.33.

During the past 12 months, Medexus Pharmaceuticals's average Book Value Per Share Growth Rate was 45.60% per year. During the past 3 years, the average Book Value Per Share Growth Rate was 12.40% per year. During the past 5 years, the average Book Value Per Share Growth Rate was -9.30% per year. During the past 10 years, the average Book Value Per Share Growth Rate was 8.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the book value growth rate using book value per share data.

During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Medexus Pharmaceuticals was 106.10% per year. The lowest was -42.80% per year. And the median was -13.40% per year.

Medexus Pharmaceuticals's current price is $2.23. Its book value per share for the quarter that ended in Sep. 2024 was $1.33. Hence, today's PB Ratio of Medexus Pharmaceuticals is 1.68.

During the past 13 years, the highest P/B Ratio of Medexus Pharmaceuticals was 25.37. The lowest was 0.75. And the median was 2.52.


Medexus Pharmaceuticals Book Value per Share Historical Data

The historical data trend for Medexus Pharmaceuticals's Book Value per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medexus Pharmaceuticals Book Value per Share Chart

Medexus Pharmaceuticals Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Book Value per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.68 0.94 0.89 1.11 1.24

Medexus Pharmaceuticals Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Book Value per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.91 1.21 1.24 1.33 1.33

Competitive Comparison of Medexus Pharmaceuticals's Book Value per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Medexus Pharmaceuticals's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medexus Pharmaceuticals's PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Medexus Pharmaceuticals's PB Ratio distribution charts can be found below:

* The bar in red indicates where Medexus Pharmaceuticals's PB Ratio falls into.



Medexus Pharmaceuticals Book Value per Share Calculation

Medexus Pharmaceuticals's Book Value Per Share for the fiscal year that ended in Mar. 2024 is calculated as:

Book Value Per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(30.3-0.0)/24.5
=1.24

Medexus Pharmaceuticals's Book Value Per Share for the quarter that ended in Sep. 2024 is calculated as:

Book Value Per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(32.7-0.0)/24.7
=1.33

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Theoretically it is what the shareholders will receive if the company is liquidated. Total Stockholders Equity is a balance sheet item and equal to Total Assets less Total Liabilities of the company.

Book value may include intangible items which may come from the company's past acquisitions. Book value less intangibles is called Tangible Book.


Medexus Pharmaceuticals  (OTCPK:MEDXF) Book Value per Share Explanation

Usually a company's book value and Tangible Book per Share may not reflect its true value. The assets may be carried on the balance sheets at the original cost minus depreciation. This may underestimate the true economic values of the assets. It also may over-estimate their true economic value because the assets can become obsolete.

For financial companies such as banks and insurance companies, their assets may be reported in current market value of the assets owned. Book values of financial companies are more accurate indicator of the economic value of the company.


Medexus Pharmaceuticals Book Value per Share Related Terms

Thank you for viewing the detailed overview of Medexus Pharmaceuticals's Book Value per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Medexus Pharmaceuticals Business Description

Traded in Other Exchanges
Address
10 King Street East, Suite 600, Toronto, ON, CAN, M5C 1C3
Medexus Pharmaceuticals Inc is a specialty pharmaceutical company with a powerful North American commercial platform and a growing portfolio of inventive and rare disease treatment solutions. The company's focus is on the therapeutic areas of oncology, hematology, rheumatology, auto-immune diseases, allergy, and dermatology.